US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Global X Video Games & Esports ETF

25.62

+0.08000.31%

Post-market: 25.640.0200+0.08%16:15 EDT

Volume:84.52K

Turnover:2.16M

Market Cap:64.56M

PE:-0.04

High:25.77

Open:25.43

Low:25.31

Close:25.54

52wk High:34.68

52wk Low:24.89

Shares:2.52M

Float Shares:2.52M

Volume Ratio:2.05

T/O Rate:3.35%

Dividend:0.48

Dividend Rate:1.88%

EPS(TTM):-662.1600

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Aardvark Therapeutics Plans to Unblind HERO and OLE Data to Inform Path Forward Following FDA Clinical Hold

Press Release: Aardvark Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates

JCI Rises to 6,971.95: Top Gainers and Losers

Aardvark Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/HERO"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HERO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HERO\",,,,,undefined,":{"symbol":"HERO","market":"US","secType":"STK","nameCN":"Global X Video Games & Esports ETF","latestPrice":25.62,"timestamp":1780084800000,"preClose":25.54,"halted":0,"volume":84523,"hourTrading":{"tag":"盘后","latestPrice":25.64,"preClose":25.62,"latestTime":"16:15 EDT","volume":16,"amount":408.82,"timestamp":1780085715335,"change":0.02,"changeRate":0.000781,"amplitude":0},"delay":0,"changeRate":0.003132341425215421,"floatShares":2520000,"shares":2520000,"eps":-662.16,"marketStatus":"Market Closed","change":0.08,"latestTime":"05-29 16:00:00 EDT","open":25.43,"high":25.7683,"low":25.311,"amount":2164507,"amplitude":0.017905,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":-662.16,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1780300800000},"marketStatusCode":7,"adr":0,"listingDate":1572494400000,"exchange":"NASDAQ","adjPreClose":25.54,"sharesOutstanding":3230000,"nav":25.46,"aum":64153360.53,"dividendRate":0.018829,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":25.64,"preClose":25.62,"latestTime":"16:15 EDT","volume":16,"amount":408.82,"timestamp":1780085715335,"change":0.02,"changeRate":0.000781,"amplitude":0},"volumeRatio":2.0513996749275036,"impliedVol":0.1145,"impliedVolPercentile":0.6135},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HERO\",,,,,undefined,":{"symbol":"HERO","floatShares":2520000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.0513996749275036,"shares":2520000,"dividePrice":0.4824,"high":25.7683,"amplitude":0.017905,"preClose":25.54,"low":25.311,"week52Low":24.89,"pbRate":"--","week52High":34.68,"institutionHeld":0.5073,"latestPrice":25.62,"eps":-662.16,"divideRate":0.018829,"volume":84523,"delay":0,"ttmEps":-662.16,"open":25.43,"prevYearClose":29.7565,"prevWeekClose":25.52,"prevMonthClose":26.5891,"prevQuarterClose":25.73,"fiveDayClose":25.45,"twentyDayClose":26.5891,"sixtyDayClose":26.8772},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HERO\",params:#limit:5,,,undefined,":[{"date":"2025-12-30","symbol":"HERO","amount":0.332932,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Global X Video Games & Esports ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-07","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2026-01-07"},{"date":"2025-06-27","symbol":"HERO","amount":0.14964,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-27","defaultRemindTime":1751031000000,"name":"Global X Video Games & Esports ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-07","payableDate":"2025-06-27","currency":"USD","dateTimestamp":1750996800000,"payDate":"2025-07-07"},{"date":"2024-12-30","symbol":"HERO","amount":0.20754,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-30","defaultRemindTime":1735569000000,"name":"Global X Video Games & Esports ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-01-07","payableDate":"2024-12-30","currency":"USD","dateTimestamp":1735534800000,"payDate":"2025-01-07"},{"date":"2024-06-27","symbol":"HERO","amount":0.04107,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-27","defaultRemindTime":1719495000000,"name":"Global X Video Games & Esports ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-05","payableDate":"2024-06-27","currency":"USD","dateTimestamp":1719460800000,"payDate":"2024-07-05"},{"date":"2023-12-28","symbol":"HERO","amount":0.120779,"announcedDate":"2023-12-27","type":"dividend","market":"US","newRecordDate":"2023-12-29","defaultRemindTime":1703773800000,"name":"Global X Video Games & Esports ETF","recordDate":"2024-01-08","payableDate":"2023-12-29","currency":"USD","dateTimestamp":1703739600000,"payDate":"2024-01-08"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HERO\",market:\"US\",,,undefined,":[{"executeDate":"2019-12-30","recordDate":"2019-12-31","paymentDate":"2020-01-08","value":0.027784,"currency":"USD"},{"executeDate":"2020-06-29","recordDate":"2020-06-30","paymentDate":"2020-07-08","value":0.012223,"currency":"USD"},{"executeDate":"2020-12-30","recordDate":"2020-12-31","paymentDate":"2021-01-08","value":0.003605,"currency":"USD"},{"executeDate":"2021-06-29","recordDate":"2021-06-30","paymentDate":"2021-07-08","value":0.025409,"currency":"USD"},{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-07","value":0.06645,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HERO\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HERO\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2635251837","title":"Aardvark Therapeutics Plans to Unblind HERO and OLE Data to Inform Path Forward Following FDA Clinical Hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2635251837","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635251837?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:01","pubTimestamp":1778788860,"startTime":"0","endTime":"0","summary":"SAN DIEGO, May  14, 2026  (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark or the Company) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecu","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/14/3295315/0/en/Aardvark-Therapeutics-Plans-to-Unblind-HERO-and-OLE-Data-to-Inform-Path-Forward-Following-FDA-Clinical-Hold.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD","IND","BK4588","LABU","HERO","BK4585","BK4007","PWS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633410771","title":"Press Release: Aardvark Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2633410771","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633410771?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:00","pubTimestamp":1778155200,"startTime":"0","endTime":"0","summary":"ARD-101 and ARD-201 programs on voluntary pause; further guidance expected in Q2 2026. $91.2 million in cash, cash equivalents and short-term investments as of March 31, 2026, supports projected operations into mid-2027. SAN DIEGO, May 07, 2026  -- Aardvark Therapeutics, Inc.  , a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, today reported financial results for the first quarter ended March 31, 2026, and provided pipeline and business updates.\"We have been working closely with the FDA to comprehensively evaluate the data following the reversible cardiac observations in the healthy volunteer trial and are committed to determining the best path forward for our programs, patients and the broader PWS community,\" said Tien Lee, M.D., Founder and Chief Executive Officer of Aardvark. \"We remain focused on establishing a clear path forward for the Phase 3 HERO t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128525929.USD","LU1267930490.SGD","LU1267930573.SGD","LU0128526141.USD","LU0029864427.USD","LU1989763690.USD","AARD","LU0029874061.USD","LU1892829315.USD","LU0708994859.HKD","LU0310799852.SGD","LU1803068623.USD","CCK","BK4126","HERO","BK4007","LU0211328371.USD","PWS","LU0211327993.USD","LU1989763427.SGD","LU0310800379.SGD","LU0054578231.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633957849","title":"JCI Rises to 6,971.95: Top Gainers and Losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2633957849","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633957849?lang=en_us&edition=fundamental","pubTime":"2026-05-04 21:31","pubTimestamp":1777901482,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta-The Jakarta Composite Index  strengthened to 6,971.95 at the close of today's trading, Monday, May 4, 2026. This number increased by 0.22 percent from the previous Thursday's closing at 6,956.80.Although it briefly rose to 7,067.05, JCI was unable to hold around 7,000 until the close of trading. The level today is still the lowest throughout this year, while the highest level was 9,134.70 on January 20, 2026.The Indonesia Stock Exchange  recorded 10 stocks that were the top gainers today, namely:","market":"nz","thumbnail":"https://statik.tempo.co/data/2026/04/02/id_1467053/1467053_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2026/04/02/id_1467053/1467053_720.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2101830/jci-rises-to-6971-95-top-gainers-and-losers","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2101830/jci-rises-to-6971-95-top-gainers-and-losers","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["CASH","IE00B19Z9Z06.USD","IDX.AU","LU0353189763.USD","BK4086","BK4588","LU0320765489.SGD","LU1989764748.USD","IDX","BK4211","LU1989772923.USD","LU1791710400.SGD","BK4580","COAL","LU0312595415.SGD","IE0001KFT4U8.USD","IE00B19Z3B42.SGD","LU1854103824.USD","LU1989772840.SGD","LU0070302665.USD","IE00B7SZLL34.SGD","IE00B894F039.SGD","BK4585","LU0154236417.USD","IE00B19Z3581.USD","LU0124384867.USD","LU0211331839.USD","LU1989764664.SGD","LU0353189680.USD","LU1854104046.USD","IE00B19Z9P08.USD","IE0002270589.USD","LU1978683503.SGD","HERO","LU0528227936.USD","LU2087625088.SGD","INDS","JCI","IE00B3T34201.USD","LU0208291251.USD","IE00BZ9MQY76.HKD","BK4504","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621084925","title":"Aardvark Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2621084925","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621084925?lang=en_us&edition=fundamental","pubTime":"2026-03-24 04:05","pubTimestamp":1774296300,"startTime":"0","endTime":"0","summary":"Voluntary pause of the Phase 3 HERO and OLE trials evaluating ARD-101 for the treatment of hyperphagia in individuals with Prader-Willi Syndrome, further guidance on the program expected in Q2 2026 AR","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/23/3260833/0/en/Aardvark-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Business-Updates.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128525929.USD","LU0054578231.USD","CCK","LU1803068623.USD","LU0310799852.SGD","LU0310800379.SGD","AARD","LU0029864427.USD","LU0029874061.USD","BK4126","LU1267930573.SGD","LU0211328371.USD","PWS","LU0211327993.USD","LU1892829315.USD","LU1267930490.SGD","LU0128526141.USD","BK4007","HERO","LU0708994859.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/HERO\",params:#limit:6,delay:false,,,undefined,":[]}}